Lv3
310 积分 2022-11-17 加入
PRESTO: A Phase III, Open-Label Study of Intensification of Androgen Blockade in Patients With High-Risk Biochemically Relapsed Castration-Sensitive Prostate Cancer (AFT-19)
2天前
已完结
Androgen receptor interacting proteins in prostate cancer development and therapy resistance
3个月前
已完结
Survival outcome of chemotherapy-naïve castration-resistant prostate cancer treated with new-generation androgen receptor axis-targeted agents in real-world analysis
3个月前
已完结
Real world evidence of enfortumab vedotin in patients with advanced urothelial cancer: A multicenter observational study
3个月前
已完结
Genomic Profiling of Metastatic Castration-Resistant Prostate Cancer Samples Resistant to Androgen Receptor Pathway Inhibitors
7个月前
已完结
Effect of Prior Local Therapy on Response to First-line Androgen Receptor Axis Targeted Therapy in Metastatic Castrate-resistant Prostate Cancer: A Secondary Analysis of the COU-AA-302 Trial
11个月前
已完结
Association Between 5α-Reductase Inhibitors and Prostate Cancer Mortality
11个月前
已完结
Adjuvant immunotherapy in renal cell carcinoma: A living systematic review and network meta-analysis (NMA)
1年前
已完结
Effect of Focal vs Extended Irreversible Electroporation for the Ablation of Localized Low- or Intermediate-Risk Prostate Cancer on Early Oncological Control
1年前
已完结
Genomic Profiling and Response to Immune Checkpoint Inhibition plus Tyrosine Kinase Inhibition in FH-Deficient Renal Cell Carcinoma
1年前
已完结
皖公网安备34019202002308
